AI-generated analysis. Always verify with the original filing.
Picard Medical, Inc. issued a press release announcing that a 29-year-old patient was sustained entirely by the SynCardia Total Artificial Heart for 1,636 days from September 2, 2021, until a successful heart transplant on February 24, 2026. This case illustrates the device's potential for extended bridge-to-transplant support in biventricular heart failure patients.
Event Type
Disclosure
Voluntary
Variant
8-K
. Regulation FD Disclosure. On March 17, 2026, Picard Medical, Inc. (the “Company”) issued a press release announcing that a 29-year-old patient had been sustai
. Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press R